Radioimmunoassay for serum myoglobin
Annals of Clinical and Laboratory Science
|July 1, 1978
Summary
A new radioimmunoassay accurately measures serum myoglobin, a key indicator of heart damage. Elevated myoglobin levels post-myocardial infarction suggest ongoing cardiac issues.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Background:
- Serum myoglobin is a biomarker for myocardial infarction.
- Accurate and timely measurement of myoglobin is crucial for diagnosing cardiac damage.
Purpose of the Study:
- To develop and validate a column flow-through radioimmunoassay for serum myoglobin.
- To assess the utility of this assay in detecting myocardial infarction.
Main Methods:
- Antibodies to human or rhesus monkey myoglobin were coupled to Sepharose.
- Myoglobin was labeled using the Chloramine-T method.
- A column flow-through radioimmunoassay was employed for serum analysis.
Main Results:
- The developed radioimmunoassay demonstrated stability of labeled myoglobin.
- Elevated serum myoglobin levels were observed within 12-24 hours post-myocardial infarction.
- Levels up to 1340 ng/ml were recorded in myocardial infarction cases.
Conclusions:
- The radioimmunoassay is effective for quantifying serum myoglobin.
- Sustained or repeated elevations indicate potential ongoing myocardial damage or re-infarction.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...